The South Korean stock markets KOSPI and KOSDAQ faced a decline on July 16, 2025, as foreign and institutional investors continued heavy selling. Despite strong individual performances by Samsung Electronics and Alteogen, the broader market fell under pressure due to macroeconomic concerns.
KOSPI and KOSDAQ Close Lower
On Tuesday, the KOSPI index dropped by 28.9 points (0.9%), ending at 3,186.38. This fall came after briefly reclaiming the 3,200 level for the first time in nearly
four years. Meanwhile, the KOSDAQ index
also slipped slightly by 0.08%
to 812.23.
Despite recent gains in big-name stocks, selling pressure from foreign and institutional investors pulled the markets downward.
Samsung & Alteogen: Bright Spots Amid Market Gloom
·
Samsung
Electronics continued its rally after news that NVIDIA received approval to resume AI
chip exports to China.
·
Alteogen
soared to an all-time high during the day, following the announcement that its ATL B4 drug patent was registered in the
U.S.
Still, these gains weren’t enough to lift the overall market. Broader sell-offs across sectors overwhelmed isolated rallies.
Who’s Selling and Why?
In the KOSPI
market,
·
Institutions
sold stocks worth ₹613.7 billion
won,
·
Foreigners
offloaded about ₹76.1 billion
won.
In the KOSDAQ,
·
Foreign
sales totaled ₹113.8 billion won,
·
Institutions
sold ₹67.5 billion won.
Much of this selling came from program trading, particularly non-arbitrage transactions. These types of trades usually affect multiple large-cap stocks at once, amplifying the impact across the market.
Economic Indicators Fueling Nervousness
Several global signals increased investor
caution:
·
The Korean
won weakened against the U.S.
dollar, settling at 1,385.7 won,
up 5.5 won from the previous
session.
·
The 10-year
U.S. Treasury yield climbed near 4.5%, signaling reduced appetite for risk.
·
Concerns over inflation and tariffs,
particularly from potential policies
under Donald Trump, added to the pressure.
Even though the U.S. Consumer Price Index (CPI) met expectations, rising commodity prices and tariff uncertainties worried investors.
US Fed Rate Cut Hopes Fading
Recent market data shows that expectations for
a rate cut in September by the U.S.
Federal Reserve have declined:
·
The CME
FedWatch Tool suggests a 54%
chance of a rate cut, down from 70%
a week ago.
·
The chance of a rate freeze rose to 46%, reflecting increasing doubt in economic easing.
This shift in expectations affects global investor sentiment, especially in emerging markets like South Korea.
What’s Next for the Market?
Analysts suggest that profit-taking was a major theme after KOSPI’s recent
high.
According to Lee Kyung-min from DAISHIN Securities, investor psychology
is shifting:
“The recent high in the KOSPI likely triggered profit-booking. Investors are now evaluating whether tariff effects on prices will be short-lived or longer-term.”
Major Stock Movements: Winners & Losers
Falling Stocks in KOSPI:
·
SK hynix
·
LG Energy
Solution
·
Hyundai
Motor
·
Mirae
Asset Securities: Down over 7%
·
Woori
Financial Group, KB Financial:
Dropped over 5%
Gainers in KOSPI:
·
Samsung
Biologics
·
Hanwha
Aerospace
·
NAVER
Top Losers in KOSDAQ:
·
ECOPRO BM
·
Ecopro
·
PharmaResearch
Top Gainers in KOSDAQ:
·
Peptron
·
Rainbow
Robotics
· LEENO Industrial
Sector Watch: Financials Fall, Tech & Parts Rise
Weak Sectors:
·
Banking
·
Insurance
·
Securities
These sectors, which recently showed momentum,
corrected sharply. Investors likely exited due to macroeconomic uncertainties.
Strong Sectors:
·
Parts and
Equipment Manufacturers:
o TOPTEC hit upper circuit after news it’s
supplying prismatic battery assembly
machines to SK On.
o Fine M-Tec and Duksan Neolux also gained due to their linkage with Apple’s rumored foldable iPhone.
Takeaway for Investors
The South Korean stock market is navigating heavy foreign institutional selling,
combined with rising U.S. bond yields,
a weaker won, and tariff fears. While companies like Samsung and Alteogen offer hope, the broader sentiment remains
cautious.
Short-term volatility may continue until
there’s clarity on:
·
U.S. inflation trends
·
Federal Reserve policy
·
Trade and tariff developments
For now, it’s a market for patient investors and those looking for value in selective sectors.
Also Read :
- Ashok Leyland Share Price Adjusted After 1:1 Bonus Issue; Stock Falls Over 50% on Ex-Bonus Date
- Anthem Biosciences IPO Day 3: GMP Rises, 7.4x Subscribed : Should You Invest Before July 16?
- HDFC Bank May Announce First-Ever Bonus Shares and Special Dividend with Q1 Results on July 19
- ASML ADR Q2 Earnings Smash Estimates With $5.90 EPS, Forecasts Strong Q3 Growth
0 Comments